Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas

202066 citationsJournal Articlehybrid Open Access

Authors

AbbVie Inc funded this study.

Good health and well-being

Published in: Obstetrics and Gynecology

Volume 135, Issue 6, pp. 1313-1326

Field-Weighted Citation Impact: 4.88